Smith & Wesson Swings to Loss Amidst Sales Dip

Ticker: SWBI · Form: 10-Q · Filed: Dec 4, 2025 · CIK: 1092796

Smith & Wesson Brands, Inc. 10-Q Filing Summary
FieldDetail
CompanySmith & Wesson Brands, Inc. (SWBI)
Form Type10-Q
Filed DateDec 4, 2025
Risk Levelhigh
Pages15
Reading Time18 min
Key Dollar Amounts$0.001, $0
Sentimentbearish

Sentiment: bearish

Topics: Firearms, Manufacturing, Quarterly Earnings, Net Loss, Sales Decline, Debt Increase, Material Weakness

Related Tickers: SWBI

TL;DR

**SWBI's latest 10-Q is a red flag, showing a net loss and declining sales, signaling potential headwinds for the firearms manufacturer.**

AI Summary

Smith & Wesson Brands, Inc. (SWBI) reported a net loss of $1.494 million for the six months ended October 31, 2025, a significant decline from a net income of $2.691 million in the prior-year period. For the three months ended October 31, 2025, net income decreased to $1.917 million from $4.546 million in the same period of 2024. Net sales for the six months ended October 31, 2025, were $209.748 million, down from $218.013 million in the comparable 2024 period, representing a 3.8% decrease. Gross profit also fell to $52.424 million for the six-month period, compared to $58.691 million previously. The company's cash and cash equivalents decreased to $22.431 million as of October 31, 2025, from $25.231 million at April 30, 2025. A material weakness in internal control over the accrual for certain legal expenses was identified and is undergoing remediation, with training programs expected to continue throughout fiscal 2026. Inventory levels decreased by $6.699 million for the six months ended October 31, 2025, and are expected to decline further. The company also increased its notes and loans payable to $88.992 million from $79.096 million since April 30, 2025.

Why It Matters

This filing reveals a challenging period for Smith & Wesson, with declining sales and a shift to a net loss for the six-month period, which could signal softening demand in the firearms market. For investors, this raises concerns about profitability and future growth, especially given the increase in debt and a material weakness in financial reporting. Employees might face pressure if the downturn continues, while customers could see new product introductions or pricing adjustments to stimulate demand. Competitively, this performance could indicate a broader industry trend or specific challenges for SWBI in a market that is often sensitive to political and economic factors.

Risk Assessment

Risk Level: high — The company reported a net loss of $1.494 million for the six months ended October 31, 2025, a significant drop from a $2.691 million net income in the prior year. Additionally, a material weakness in internal control over the accrual for certain legal expenses was identified, indicating potential financial reporting risks. Net sales also decreased by 3.8% to $209.748 million for the six-month period.

Analyst Insight

Investors should exercise caution and consider a 'hold' or 'sell' position given the net loss, declining sales, and identified material weakness in internal controls. Monitor the effectiveness of the remediation efforts for the control weakness and watch for any further deterioration in sales or profitability in upcoming quarters before considering new investments.

Financial Highlights

revenue
$209.748M
total Debt
$88.992M
net Income
-$1.494M
gross Margin
25.0%
cash Position
$22.431M
revenue Growth
-3.8%

Revenue Breakdown

SegmentRevenueGrowth
Firearms$209.748M-3.8%

Key Numbers

  • $1.494M — Net Loss (For the six months ended October 31, 2025, a significant decrease from $2.691M net income in the prior year.)
  • $209.748M — Net Sales (For the six months ended October 31, 2025, a 3.8% decrease from $218.013M in the prior year.)
  • $52.424M — Gross Profit (For the six months ended October 31, 2025, down from $58.691M in the prior year.)
  • $22.431M — Cash and Cash Equivalents (As of October 31, 2025, a decrease from $25.231M at April 30, 2025.)
  • $88.992M — Notes and Loans Payable (As of October 31, 2025, an increase from $79.096M at April 30, 2025.)
  • 44,493,745 — Common Shares Outstanding (As of December 2, 2025.)
  • $183.141M — Inventories (As of October 31, 2025, a decrease from $189.840M at April 30, 2025.)
  • $19.158M — Net Cash Provided by Operating Activities (For the six months ended October 31, 2025, a significant improvement from net cash used of $38.212M in the prior year.)

Key Players & Entities

  • SMITH & WESSON BRANDS, INC. (company) — Registrant and firearms manufacturer
  • Bloomberg (company) — Financial news organization
  • SEC (regulator) — Securities and Exchange Commission
  • $1.494 million (dollar_amount) — Net loss for the six months ended October 31, 2025
  • $2.691 million (dollar_amount) — Net income for the six months ended October 31, 2024
  • $209.748 million (dollar_amount) — Net sales for the six months ended October 31, 2025
  • $218.013 million (dollar_amount) — Net sales for the six months ended October 31, 2024
  • $88.992 million (dollar_amount) — Notes and loans payable as of October 31, 2025
  • $79.096 million (dollar_amount) — Notes and loans payable as of April 30, 2025
  • Maryville, Tennessee (location) — Location of principal executive offices and manufacturing facility

FAQ

What were Smith & Wesson's net sales for the six months ended October 31, 2025?

Smith & Wesson's net sales for the six months ended October 31, 2025, were $209.748 million, a decrease from $218.013 million in the same period of 2024.

Did Smith & Wesson report a net profit or loss for the recent six-month period?

Smith & Wesson reported a net loss of $1.494 million for the six months ended October 31, 2025, compared to a net income of $2.691 million in the prior-year period.

What is the current status of Smith & Wesson's cash and cash equivalents?

As of October 31, 2025, Smith & Wesson's cash and cash equivalents stood at $22.431 million, down from $25.231 million at April 30, 2025.

Has Smith & Wesson identified any material weaknesses in its internal controls?

Yes, Smith & Wesson identified an immaterial error related to its accrual for certain legal expenses, which led to the identification of a material weakness in internal control over the accrual for certain legal expenses. Remediation efforts are ongoing.

What are Smith & Wesson's plans to address the identified material weakness?

Management plans to remediate the material weakness by developing a training program for certain personnel to increase their knowledge of accruals for legal expenses. Remediation efforts and testing are expected to continue throughout fiscal 2026.

How have Smith & Wesson's inventory levels changed?

Inventories decreased by $6.699 million for the six months ended October 31, 2025, from $189.840 million at April 30, 2025, to $183.141 million at October 31, 2025. The company expects inventory levels to decline further during the remainder of the fiscal year.

What is Smith & Wesson's total debt as of October 31, 2025?

As of October 31, 2025, Smith & Wesson's notes and loans payable amounted to $88.992 million, an increase from $79.096 million at April 30, 2025.

Where does Smith & Wesson manufacture its products?

Smith & Wesson manufactures its products at facilities in Maryville, Tennessee; Springfield, Massachusetts; and Houlton, Maine. The Deep River, Connecticut facility was discontinued during fiscal 2025.

What was Smith & Wesson's basic net income per share for the three months ended October 31, 2025?

Smith & Wesson's basic net income per share was $0.04 for the three months ended October 31, 2025, a decrease from $0.10 in the same period of 2024.

What types of products does Smith & Wesson manufacture?

Smith & Wesson manufactures a wide array of handguns (revolvers and pistols), long guns (modern sporting rifles, pistol caliber carbines, lever-action rifles), handcuffs, firearm suppressors, and other firearm-related products under the Smith & Wesson and Gemtech brands.

Risk Factors

  • Material Weakness in Internal Control [high — operational]: The company identified a material weakness in its internal control over financial reporting related to the accrual for certain legal expenses. Remediation efforts are underway, including training programs expected to continue through fiscal year 2026.
  • Declining Profitability and Cash Position [medium — financial]: For the six months ended October 31, 2025, the company reported a net loss of $1.494 million, a significant decline from a net income of $2.691 million in the prior year. Cash and cash equivalents decreased to $22.431 million from $25.231 million.
  • Increased Indebtedness [medium — financial]: Notes and loans payable increased to $88.992 million as of October 31, 2025, from $79.096 million at April 30, 2025, indicating a growing reliance on debt financing.
  • Sales Decline [medium — market]: Net sales for the six months ended October 31, 2025, were $209.748 million, a 3.8% decrease from $218.013 million in the comparable 2024 period, suggesting potential market headwinds or reduced demand.

Industry Context

The firearms industry is subject to significant regulatory oversight and is sensitive to consumer demand, economic conditions, and political sentiment. Competition is intense, with companies vying for market share through product innovation and brand reputation. Recent trends may include shifts in consumer purchasing patterns and ongoing debates surrounding gun control legislation.

Regulatory Implications

The firearms industry faces stringent federal, state, and local regulations concerning manufacturing, sales, and marketing. Changes in legislation or increased enforcement can significantly impact operations and profitability. The company's identification of a material weakness in internal controls also raises concerns about compliance and financial reporting accuracy.

What Investors Should Do

  1. Monitor remediation of material weakness
  2. Analyze debt levels and cash flow
  3. Evaluate sales and profitability trends

Key Dates

  • 2025-10-31: End of Six-Month Period — Reporting period for the 10-Q, showing a net loss and decreased sales compared to the prior year.
  • 2025-04-30: End of Prior Fiscal Year — Baseline for comparison of cash, inventory, and debt levels.

Glossary

Material Weakness
A deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. (Indicates a significant flaw in the company's financial reporting processes that could lead to errors in financial statements.)
Accrual
An accounting method where revenue is recognized when earned and expenses are recognized when incurred, regardless of when cash is exchanged. (The material weakness identified relates to the proper accrual of certain legal expenses.)
Cash Equivalents
Short-term, highly liquid investments that are readily convertible to known amounts of cash and which are so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. (A key indicator of the company's short-term liquidity, which has decreased.)
Notes and Loans Payable
Obligations of the company to repay borrowed funds, typically with interest, under formal loan agreements or promissory notes. (Represents the company's short-term and long-term debt obligations, which have increased.)

Year-Over-Year Comparison

Compared to the prior year's comparable period, Smith & Wesson Brands, Inc. has experienced a shift from net income to a net loss of $1.494 million for the six months ended October 31, 2025. Net sales have declined by 3.8% to $209.748 million, and gross profit has also decreased. While net cash provided by operating activities has improved significantly from a negative to a positive $19.158 million, the company's cash position has weakened, and its total debt has increased.

Filing Stats: 4,471 words · 18 min read · ~15 pages · Grade level 18.7 · Accepted 2025-12-04 16:15:45

Key Financial Figures

  • $0.001 — ch registered Common Stock, par value $0.001 per share SWBI The Nasdaq Stock Mar
  • $0 — 3,745 shares of common stock, par value $0.001, outstanding as of December 2, 2025

Filing Documents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) 4

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 20

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 27

Controls and Procedures

Item 4. Controls and Procedures 27

- OTHER INFORMATION

PART II - OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 29

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29

Other Information

Item 5. Other Information 29

Exhibits

Item 6. Exhibits 30

Signatures

Signatures 31 EX-31.1 EX-31.2 EX-32.1 EX-32.2 Smith & Wesson, S&W, M&P, M&P Shield, Performance Center, Abyss, Airlite, Airweight, American Guardians, Armornite, Arrow, Aurora-II, Blast Jacket, Bodyguard, Carry Comp, Chiefs Special, Club 1852, Competitor, CSX, Dagger, Empowering Americans, E-Series, ETM, EZ, Flexmag, G-Core, Gemtech, Gemtech Suppressors, GM, GM-S1, GMT-Halo, Governor, GVAC, Integra, Lady Smith, Lever Lock, Lunar, M&P FPC, M2.0, Magnum, Mist-22, Model 1854, Mountain Gun, Protected by Smith & Wesson, Put A Legend On Your Line, Quickmount, Shield, Silence is Golden, Smith & Wesson Collectors Association, Smith & Wesson Performance Center, Smith & Wesson Precision Components, Smith & Wesson Response, SW Equalizer, SW22 Victory, TEMPO, The S&W Bench, Trek, Volunteer, and Weather Shield are some of the registered U.S. trademarks of our company or one of our subsidiaries. This Quarterly Report on Form 10-Q also may contain trademarks and trade names of other companies. The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. All statements other than statements of historical facts contained or incorporated herein by reference in this Quarterly Report on Form 10-Q, including statements regarding our future operating results, future financial position, business strategy, objectives, goals, plans, prospects, markets, and plans and objectives for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as "anticipates," "believes," "estimates," "expects," "intends," "targets," "contemplates," "projects," "predicts," "may," "might," "plan," "will," "would," "should," "could," "can," "potential," "contin

Financi al Statements

Item 1. Financi al Statements SMITH & WESSON BRANDS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDAT ED BALANCE SHEETS (Unaudited) As of: October 31, 2025 April 30, 2025 (In thousands, except par value and share data) ASSETS Current assets: Cash and cash equivalents $ 22,431 $ 25,231 Marketable securities 4,890 — Accounts receivable, net of allowances for credit losses of $ 5 on October 31, 2025 and April 30, 2025 45,834 55,868 Inventories 183,141 189,840 Prepaid expenses and other current assets 9,655 6,260 Income tax receivable 2,569 66 Total current assets 268,520 277,265 Property, plant, and equipment, net of accumulated depreciation and amortization of $ 384,186 on October 31, 2025 and $ 368,811 on April 30, 2025 242,082 242,648 Intangibles, net 2,278 2,409 Goodwill 19,024 19,024 Deferred income taxes 9,584 10,260 Other assets 7,094 8,006 Total assets $ 548,582 $ 559,612 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 23,485 $ 26,887 Accrued expenses and deferred revenue 18,658 24,678 Accrued payroll and incentives 10,303 9,060 Accrued profit sharing 204 4,636 Accrued warranty 1,241 1,379 Total current liabilities 53,891 66,640 Notes and loans payable (Note 3) 88,992 79,096 Finance lease payable, net of current portion 32,806 33,703 Other non-current liabilities 9,697 7,719 Total liabilities 185,386 187,158 Commitments and contingencies (Note 8) Stockholders' equity: Preferred stock, $ 0.001 par value, 20,000,000 shares authorized, no shares issued or outstanding — — Common stock, $ 0.001 par value, 100,000,000 shares authorized, 76,168,890 issued and 44,490,896 shares outstanding on October 31, 2025 and 75,789,455 shares issued and 44,111,461 shares outstanding on April 30, 2025 76 76 Additional paid-in capital 301,933 298,075 Retained earnings

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.